{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:35:23Z","timestamp":1790523323259,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T00:00:00Z","timestamp":1493424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T00:00:00Z","timestamp":1493424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG034676"],"award-info":[{"award-number":["R01AG034676"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00408-017-0012-7","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T05:50:51Z","timestamp":1493445051000},"page":"411-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hospitalization Among Patients with Sarcoidosis: A Population-Based Cohort Study 1987\u20132015"],"prefix":"10.1007","volume":"195","author":[{"given":"Patompong","family":"Ungprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,29]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1378\/chest.123.2.406","volume":"123","author":"MA Judson","year":"2003","unstructured":"Judson MA, Thompson BW, Rabin DL et al (2003) The diagnostic pathway to sarcoidosis. Chest 123:406\u2013412","journal-title":"Chest"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","volume":"170","author":"LS Newman","year":"2004","unstructured":"Newman LS, Rose CS, Bresnitz EA et al (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170:1324\u20131330","journal-title":"Am J Respir Crit Care Med"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Field S, Costabel U et al (2016) Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc 13:1244\u20131452","journal-title":"Ann Am Thorac Soc"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccm.2008.03.011","volume":"29","author":"ES Chen","year":"2008","unstructured":"Chen ES, Moller DR (2008) Etiology of sarcoidosis. Clin Chest Med 29:365\u2013377","journal-title":"Clin Chest Med"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2466-12-19","volume":"12","author":"AK Gerke","year":"2012","unstructured":"Gerke AK, Yang M, Tang F et al (2012) Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study. BMC Pulm Med 12:19","journal-title":"BMC Pulm Med"},{"key":"12_CR6","first-page":"124","volume":"23","author":"MG Foreman","year":"2006","unstructured":"Foreman MG, Mannino DM, Kamugisha L et al (2006) Hospitalization for patients with sarcoidosis: 1979\u20132000. Sarcoidosis Vasc Diffuse Lung Dis 23:124\u2013129","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"e0151940","DOI":"10.1371\/journal.pone.0151940","volume":"11","author":"S Pohle","year":"2016","unstructured":"Pohle S, Baty F, Brutsche M (2016) In-hospital disease burden of sarcoidosis in Switzerland from 2002 to 2012. PLoS ONE 11:e0151940","journal-title":"PLoS ONE"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1378\/chest.126.5.1431","volume":"126","author":"ED Gorham","year":"2004","unstructured":"Gorham ED, Garland CE, Garland FC et al (2004) Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel. A 27-year historical prospective study 1975\u20132001. Chest 126:1431\u20131438","journal-title":"Chest"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","volume":"91","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Carmona EM, Utz JP et al (2016) Epidemiology of sarcoidosis 1946\u20132013: a population-based study. Mayo Clin Proc 91:183\u2013188","journal-title":"Mayo Clin Proc"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","volume":"87","author":"WA Rocca","year":"2012","unstructured":"Rocca WA, Yawn BP, Sauver JL et al (2012) History of the Rochester Epidemiology Project: half a century of medical records linkage in a U.S. population. Mayo Clin Proc 87:1202\u20131213","journal-title":"Mayo Clin Proc"},{"key":"12_CR11","unstructured":"Healthcare Cost and Utilization Project. HCUPnet.\u00a0\n                    http:\/\/hcupnet.ahrq.gov\/"},{"key":"12_CR12","first-page":"158","volume":"17","author":"A Pietinalho","year":"2000","unstructured":"Pietinalho A, Ohmichi M, Lofroos AB et al (2000) The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis 17:158\u2013166","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1164\/ajrccm.149.4.8143052","volume":"149","author":"GW Hunninghake","year":"1994","unstructured":"Hunninghake GW, Gilbert S, Oueringer R et al (1994) Outcome of the treatment of sarcoidosis. Am J Resp Crit Care Med 149:893\u2013898","journal-title":"Am J Resp Crit Care Med"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00408-016-9952-6","volume":"195","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL (2017) Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976-2013. Lung 195:87\u201391","journal-title":"Lung"},{"key":"12_CR15","first-page":"380","volume":"34","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Sellares J, Bosch X (2016) Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences. Clin Exp Rheumatol 34:380\u2013388","journal-title":"Clin Exp Rheumatol"},{"key":"12_CR16","first-page":"119","volume":"29","author":"MA Judson","year":"2012","unstructured":"Judson MA, Boan AF, Lackland DT (2012) The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis 29:119\u2013127","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0954-6111(03)00127-6","volume":"97","author":"H Yanardag","year":"2003","unstructured":"Yanardag H, Nuri Pamuk O, Karayel T (2003) Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 97:978\u2013982","journal-title":"Respir Med"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1378\/chest.14-1120","volume":"147","author":"M Mirsaedi","year":"2015","unstructured":"Mirsaedi M, Machado RF, Schraufnagel D et al (2015) Racial difference in sarcoidosis mortality in the United States. Chest 147:438\u2013449","journal-title":"Chest"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1183\/09031936.04.00070503","volume":"24","author":"DL Rabin","year":"2004","unstructured":"Rabin DL, Thompson B, Brown KM et al (2004) Sarcoidosis: social predictors of severity at presentation. Eur Resp J 24:601\u2013608","journal-title":"Eur Resp J"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-017-0012-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-017-0012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-017-0012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T06:23:41Z","timestamp":1589696621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-017-0012-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,29]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s00408-017-0012-7","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,29]]},"assertion":[{"value":"6 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no financial or non-financial potential conflicts of interest to declare. Dr. Carmona is a CO-I in a registry for patients with sarcoidosis-associated pulmonary hypertension. The study is funded by Gilead.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}